4 assets in Endocrine System Disorder

Therapeutic assets addressing Endocrine System Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Endocrine System Disorder	Wenjun Cheng	P2	CCC (53)
Catequentinib Endocrine System Disorder	Wenjun Cheng	P2	CCC (53)
azd6234 Endocrine System Disorder	AstraZeneca	P2	NR ()